Low Dose Ketamine Versus Morphine for Moderate to Severe Pain in the Emergency Department
Completed · Phase 4
Conditions studied: Pain
In brief
The primary objectives of the study are to evaluate the efficacy of subdissociative dose intravenous ketamine compared with intravenous morphine in relieving acute pain in the ED. Secondary objectives will include the rate of adverse effects and need for rescue analgesia. The hypothesis is that intravenous administration of subdissociative dose ketamine at 0.3 mg/kg is superior to intravenous morphine at 0.1mg/kg in treating moderate and severe acute pain in patients presenting to the ED.
Key facts
- Study ID
- NCT01835262
- Run by
- Antonios Likourezos
- People needed
- 90
- Starts
- 2013-04-01
- Expected to finish
- 2014-05-01
- Last updated by the study team
- 2016-02-29
Who can join
Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- ED patients18-55 years old presenting with moderate to severe (Numeric Pain Rating Score >5) acute (less than 7 days)
- abdominal, flank, back or musculoskeletal pain warranting (in the treating physician's judgment) administration of intravenous opioid pain medication.
- Patients must be awake, alert and oriented to time, place and person,
- patient must be able to demonstrate understanding of the informed consent.
- Patient must be able to verbalize how much pain they are having on the 10 point Numeric Rating Pain Scale,
- Patient mus be able to verbalize the nature of the side effects he may be experiencing from the intravenous analgesia.
You may not qualify if…
- Pregnancy or breast feeding
- SBP<90
- Weight greater than 115kg or less than 45kg,
- altered mental status,
- allergy to ketamine or morphine,
- history of acute head or ocular trauma
- presence of intracranial mass or vascular lesion, presence of psychiatric history
- diagnosis or treatment (as assessed by electronic chart review).
- history of seizure or intracranial hypertension
- history of chronic pain, pain syndrome or fibromyalgia
- presence of cardiovascular disease except controlled hypertension
- history of acute head or ocular trauma, drug or alcohol abuse in the preceding 6 months
- drugs or alcohol abuse in the preceding 6 months
- SBP>180
- HR<50
- HR>150
- RR<10
- RR>30
- administration of opiate pain medication in the past 4 hours prior to assessment (i.e. home, EMS, triage, office, etc.)
- presence of renal or hepatic insufficiency (as assessed by electronic chart review),
Where it is running
- Maimonides Medical Center — Brooklyn, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.